[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2014/07/Baby_with_Biostamp.png” thumb_width=”180″ /][grow_thumb image=”https://telecareaware.com/wp-content/uploads/2014/07/MC10_Biostamp-small.jpg” thumb_width=”150″ /]Perhaps we should be adding to our sidebar lexicon ‘conformal electronics’.
Boston-based wearable health technology developer MC10
is partnering with Brussels-based biopharmaceutical company UCB S.A.
to develop MC10’s Biostamp platform
for treating those with severe neurological disorders. MC10 developed a seamless, disposable sensing sticker with thin film batteries (right above) which is currently in use in the Reebok Checklight
to determine sports-related concussion risk [TTA 16 May
, “Brain Games”] and in beta for infant temperature sensing (left above). It seems clear from the announcement today and further remarks (see below) that the objective is not drug delivery, but for patient monitoring and disease management. MC10 commercializes John Rogers’
work in stretchable sensor patches and batteries [TTA 10 April
]. The Biostamp does not have FDA approval but the partnership may be a way to fast-track CE approval. MC10 release, Fast Company
(also reviews Proteus, Corventis, Given Imaging
with comments from Ben Schlatka, MC10 cofounder.
One of the greatest misconceptions I had when I first got involved in telecare was that the main reason that people don’t adhere to their medication regime is that they forget to take their medicine – therefore all they need is an automated pill dispenser or perhaps even an alerting system and all will be well. If only it was so simple!
In reality there are all sorts of reasons, such as (more…)